|

Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease

RECRUITINGSponsored by Assiut University
Actively Recruiting
SponsorAssiut University
Started2023-12-01
Est. completion2024-09-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04720560

Summary

To evaluate the role of regulatory B cells in the pathogenesis of metabolic associated fatty liver disease patients.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* All patients aged \>18 years old and was diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques.

Exclusion Criteria:

* 1-Patients aged ≤18 years old. 2-Pregnancy. 3-Presence of malignancy. 4-Type I DM. 5-Fatty liver patients on treatment by statin derivatives or other medications. 6- Fatty liver patients undergone bariatric surgeries.

Conditions2

Liver DiseaseNon Alcoholic Fatty Liver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.